Biogen (BIIB) has significantly outperformed the S&P 500 over the last six months. The stock currently trades at $183.50 after a period of robust growth.
- BIIB shares increased by 25.5% over a six-month window
- Stock outperformed the S&P 500 by 19.7%
- Current trading price stands at $183.50
- Recent gains were supported by strong quarterly earnings reports
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.